Survival of patients with testicular cancer in Lithuania during 1999-2002

Medicina

Volumn 47, Issue 1, 2011, Pages 52-56

  Juška, Agnius ^a   Ulys, Albertas ^a   Kaireviçe, Laura ^b   Smailyte, Giedre ^a   Stankeviçius, Edgaras ^b   Jançiauskiene, Rasa ^b   Jievaltas, Mindaugas ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Kaplan Meier method; Log rank test; Survival; Testicular cancer

Indexed keywords

EID: 79959202491     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina47010008     Document Type: Article

References (14)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Lyon: IARC; 2001.
3. Moller H, Evans H. Epidemiology of gonadal germ cell cancer in males and females. APMIS 2003;111:43-6.
4. Moller H, Friis S, Kjaer SK. Survival of Danish cancer patients 1943-1987. Male genital organs. APMIS 1993;Suppl 33:122-36.
5. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377-99.
6. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993;23: 8-13.
7. Richiardi L, Bellocco R, Adami HO, Barlow L, Hakulinen T, Rahu M, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004;13:2157-66.
8. STATA 8.0, Stata Corporation, 2003; College Station, Texas 77845 USA.
9. Parkin DM, Whelan SL, Ferlay J. Cancer incidence in five continents. Lyon: IARC; 2002. vol. 8. Publication no. 155.
10. Berrino F, Micheli A, Sant M, Capocaccia R. Interpreting survival differences and trends. Tumouri 1997;83:9-16.
11. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 2003;14(Suppl 5):v61-118.
12. Smailytė G, Kaçėnienė A, Ulys A, Kardelis Ž. SėklidžiU{ogonek} vėžys Lietuvoje 1978-2007 metais: paamžinės sergamumo struktŪros ir histologiniU{ogonek} formU{ogonek} dažnumo pokyçiai. (Tes-ticular cancer in Lithuanian during 1978-2007: changes in morbidity and frequency of histological forms.) Sveikatos mokslai 2009;19:2787-91.
13. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet 2006;367:754-65.
14. Schmoll HJ, Jordan K, Huddart R, Laguna MP, Horwich A, Fizazi K, et al. Testicular seminoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(Suppl 4):83-9.